DS
CTIC

DRW Securities’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

DRW Securities’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-55,561
Closed -$277K – 137
2018
Q2 		$277K Buy
55,561
+4,000
+8% +$17.5K 0.02% 54
2018
Q1 		$201K Hold
51,561
– – 0.02% 120
2017
Q4 		$138K Buy
51,561
+35,000
+211% +$103K 0.03% 429
2017
Q3 		$53K Buy
+16,561
New +$55.3K 0.04% 59
2015
Q3 		– Sell
-25,000
Closed -$488K – 169
2015
Q2 		$488K Sell
25,000
-23,695
-49% -$457K 0.44% 69
2015
Q1 		$881K Buy
+48,695
New +$1.1M 0.6% 43

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return